Search research articles
Contact Us
Filters
Showing results (21-30 of 198) with videos related to
Page
of 20
Sort By:
World Journal of Diabetes
|
May 4, 2011
Combination drug treatment in obese diabetic patients
Theodosios D Filippatos, Moses S Elisaf
World Journal of Hepatology
|
December 17, 2010
Combination drug treatment in patients with non-alcoholic fatty liver disease
Theodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy
|
April 5, 2014
Antihypertensive drug therapy in patients with African ancestry
Christos V Rizos, Moses S Elisaf
European Journal of Pharmacology
|
March 19, 2013
Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease
Evangelos C Rizos, Moses S Elisaf
World Journal of Diabetes
|
October 23, 2013
Effects of glucagon-like peptide-1 receptor agonists on renal function
Theodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology
|
August 24, 2011
JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses
Michael S Kostapanos, Moses S Elisaf
Current Medical Research and Opinion
|
September 7, 2013
Hyperphosphatemia and phosphate binders: effectiveness and safety
Rigas G Kalaitzidis, Moses S Elisaf
Current Pharmaceutical Design
|
September 18, 2013
Sodium-glucose co-transporter 2 inhibition in diabetes treatment: current evidence and future perspectives
Evangelos C Rizos, Moses S Elisaf
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
May 29, 2014
Colonoscopy preparation-induced disorders in renal function and electrolytes
Matilda Florentin, George Liamis, Moses S Elisaf
Current Pharmaceutical Design
|
January 5, 2013
How should we treat hypertension and dyslipidemia in patients with prediabetes?
Vasilios Tsimihodimos, Matilda Florentin, Moses S Elisaf
Page
of 20
Search research articles
Search
Showing results (21-30 of 198) with videos related to
Sort By:
Page
of 20
World Journal of Diabetes
|
May 4, 2011
Combination drug treatment in obese diabetic patients
Theodosios D Filippatos, Moses S Elisaf
World Journal of Hepatology
|
December 17, 2010
Combination drug treatment in patients with non-alcoholic fatty liver disease
Theodosios D Filippatos, Moses S Elisaf
Expert Opinion on Pharmacotherapy
|
April 5, 2014
Antihypertensive drug therapy in patients with African ancestry
Christos V Rizos, Moses S Elisaf
European Journal of Pharmacology
|
March 19, 2013
Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease
Evangelos C Rizos, Moses S Elisaf
World Journal of Diabetes
|
October 23, 2013
Effects of glucagon-like peptide-1 receptor agonists on renal function
Theodosios D Filippatos, Moses S Elisaf
World Journal of Cardiology
|
August 24, 2011
JUPITER and satellites: Clinical implications of the JUPITER study and its secondary analyses
Michael S Kostapanos, Moses S Elisaf
Current Medical Research and Opinion
|
September 7, 2013
Hyperphosphatemia and phosphate binders: effectiveness and safety
Rigas G Kalaitzidis, Moses S Elisaf
Current Pharmaceutical Design
|
September 18, 2013
Sodium-glucose co-transporter 2 inhibition in diabetes treatment: current evidence and future perspectives
Evangelos C Rizos, Moses S Elisaf
World Journal of Gastrointestinal Pharmacology and Therapeutics
|
May 29, 2014
Colonoscopy preparation-induced disorders in renal function and electrolytes
Matilda Florentin, George Liamis, Moses S Elisaf
Current Pharmaceutical Design
|
January 5, 2013
How should we treat hypertension and dyslipidemia in patients with prediabetes?
Vasilios Tsimihodimos, Matilda Florentin, Moses S Elisaf
Page
of 20